Prof. Ana Santos Rutschman

Assistant Professor, Saint Louis University School of Law

Rutschman has published and presented widely on topics related to health law, food and drug regulation, intellectual property, innovation in the life sciences, and law and technology. Recent presentations have covered topics related to vaccines and other biotechnologies, healthcare blockchain, e-health and artificial intelligence in medicine. Her legal scholarship has appeared or is forthcoming in UCLA Law Review, Emory Law Journal, Arizona Law Review, Yale Law Journal Forum, University of Chicago Legal Forum, Michigan Law Review Online, Annals of Health Law and Duke Law and Technology Review, among others. Her peer-reviewed work has appeared in the Journal of Law and the Biosciences, the American Journal of Infection Control and Emerging Infectious Diseases. Her commentary pieces have been published by The Huffington Post and The Conversation and reprinted in Scientific American, Newsweek Japan and newspapers around the U.S., including the Chicago Tribune. Her ongoing book, Vaccines as Technology: Innovation, Barriers and the Public Interest, is under contract with Cambridge University Press.

*****

A person listed as a contributor has spoken or otherwise participated in Federalist Society events, publications, or multimedia presentations. A person's appearance on this list does not imply any other endorsement or relationship between the person and the Federalist Society. In most cases, the biographical information on a person's "contributor" page is provided directly by the person, and the Federalist Society does not edit or otherwise endorse that information. The Federalist Society takes no position on particular legal or public policy issues. All expressions of opinion by a contributor are those of the contributor.